EP Patent

EP1572164A2 — Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats

Assigned to Pain Therapeutics Inc · Expires 2005-09-14 · 21y expired

What this patent protects

The present invention relates to oral dosage form with active agents in controlled release cores and in immediate release gelatin capsule coats.

USPTO Abstract

The present invention relates to oral dosage form with active agents in controlled release cores and in immediate release gelatin capsule coats.

Drugs covered by this patent

Patent Metadata

Patent number
EP1572164A2
Jurisdiction
EP
Classification
Expires
2005-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Pain Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.